advertisement
Posted inOp-Eds, Opinion

Commentary: Who’s really keeping Ozempic and Wegovy prices so high?

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic and Wegovy. Now the question is whether those prices will change. Vermont Sen. Bernie Sanders, chair of the Senate health committee, focused his sights not […]